Phase II and Biomarker Study of Cabozantinib in Metastatic Triple-Negative Breast Cancer Patients.

ABSTRACT:

SUBMITTER: Tolaney SM 

PROVIDER: S-EPMC8342577 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature